| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/02/2006 | EP1684736A1 Dna damage repair inhibitors for treatment of cancer |
| 08/02/2006 | EP1684702A2 Use of 2-thia-dibenzo(e,h) azulenes for the treatment and prevention of central nervous system diseaes and disorders |
| 08/02/2006 | EP1435941B1 Wortmannin analogs and methods of using same |
| 08/02/2006 | EP1372737B1 Preparation for the prophylaxis of restenosis |
| 08/02/2006 | EP1326617B1 Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1165137B1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
| 08/02/2006 | EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines |
| 08/02/2006 | EP1058562B1 Compositions and methods of treating tumors |
| 08/02/2006 | EP1001785B1 Use of colchinol derivatives as vascular damaging agents |
| 08/02/2006 | EP0939621B1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 08/02/2006 | EP0758249B1 Programmable genotoxic agents and uses therefor |
| 08/02/2006 | CN1813188A Diagnosis of carcinomas |
| 08/02/2006 | CN1813000A Synthetic antibody phage libraries |
| 08/02/2006 | CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812797A Use of double-stranded ribonucleic acid for inducing cell lysis |
| 08/02/2006 | CN1812780A Cancer treatment with epothilones |
| 08/02/2006 | CN1810958A Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/02/2006 | CN1810842A Longleaf Grateloupia acuminata polysaccharide extract and its prepn and use |
| 08/02/2006 | CN1810833A Molecular design and prepn process of recombinant polyepitope chimeric peptide CP22 antigen of human chorionic gonadotropin |
| 08/02/2006 | CN1810831A Arf6 activator protein and its coding gene and application |
| 08/02/2006 | CN1810827A Anticancer prepn containing three anticancer compounds of toad or toad cake and its prepn process |
| 08/02/2006 | CN1810790A Non-metal salt of Glicididazole and its prepn |
| 08/02/2006 | CN1810284A Yunnan Rhizoma Paridis extract and its prepn, medicinal use and medicine composition |
| 08/02/2006 | CN1810247A Pharmaceutical effect of berbamine derivative EBB in inhibiting invasive metastasis of human body tumor cell |
| 08/02/2006 | CN1810239A Liver cancer cell inhibitor |
| 08/02/2006 | CN1810238A Oral arginine prepn for preventing and treating cachexia syndrome |
| 08/02/2006 | CN1810236A Liposome preparation of garlicin |
| 08/02/2006 | CN1267552C Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267452C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267450C New tumor necrosin mutein and its preparation and application |
| 08/02/2006 | CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
| 08/02/2006 | CN1267431C Substituted quinazoline derivatives and their use as inhibitors |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267154C Calcium supplementation to reduce prostate cancer risk |
| 08/02/2006 | CN1267152C Polythylene glycol-interferon alpha foreeze dried preparation |
| 08/02/2006 | CN1267122C Medicine for treating tumor |
| 08/02/2006 | CN1267120C Frozen dry powder injection of houttuynia cordata and its preparation |
| 08/02/2006 | CN1267100C Medicinal composition and its preparation and use |
| 08/02/2006 | CN1267099C Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances |
| 08/02/2006 | CN1267093C Usage of baicalin in the preparation process of tumor resisting medicine |
| 08/02/2006 | CN1267090C Garlicin injection emulsion and its preparing method |
| 08/01/2006 | US7084271 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 08/01/2006 | US7084270 Pyrimido compounds having antiproliferative activity |
| 08/01/2006 | US7084267 for the regulation of telomerase RNA genes, including the Sp family of transcription factors |
| 08/01/2006 | US7084259 G-protein coupled receptors |
| 08/01/2006 | US7084170 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | US7084167 A secondary aminemethyl-indole derivatives, for treating diseases or physiological disorders; calcimimetic activity |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084160 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084151 Urogenital disorders; dysmenorrhea; endometriosis; anticancer agents |
| 08/01/2006 | US7084149 Anticancer agents; antitumor agents |
| 08/01/2006 | US7084147 Anilinoquinazaolines as protein tyrosine kinase inhibitors |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084135 Prenyl transferase inhibitors |
| 08/01/2006 | US7084127 C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084110 Anticarcinogenic agents for treating cancer; pentapeptides, hexapeptides, heptapeptides, oligopeptides |
| 08/01/2006 | US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 08/01/2006 | US7084105 Activating adenine triphosphate independent cytolytic modulator for use in the treatment of infection and cancer; generate nutrient broth, propagate microorganisms, allow microorganism to secrete protein, recover protein |
| 08/01/2006 | US7083983 Inhibitors of the interaction between P53 and MDM2 |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083943 Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083937 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083788 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 08/01/2006 | CA2395623C Inulin products with improved nutritional properties |
| 08/01/2006 | CA2379903C Novel benzotriazoles anti-inflammatory compounds |
| 08/01/2006 | CA2245823C Farnesyl transferase inhibitors |
| 08/01/2006 | CA2192073C Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 08/01/2006 | CA2176720C Novel enzyme inhibitors, their synthesis, and methods for use |
| 08/01/2006 | CA2165435C Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 07/31/2006 | CA2493282A1 Method and composition for inhibiting cancer cell growth using urease and weakly basic anti-cancer compounds |
| 07/27/2006 | WO2006078903A1 Radiosensitizer formulations comprising nitrohistidine derivatives |
| 07/27/2006 | WO2006078422A2 Methods for modulating tumor growth and metastasis |
| 07/27/2006 | WO2006078317A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 07/27/2006 | WO2006078283A2 Quinoxaline inhibitors of hedgehog signalling |
| 07/27/2006 | WO2006078059A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | WO2006077941A1 Cancer vaccine |
| 07/27/2006 | WO2006077816A1 Imidazopyridine derivative |
| 07/27/2006 | WO2006077793A1 Antitumor agent |
| 07/27/2006 | WO2006077724A1 Cancer vaccine preparation |
| 07/27/2006 | WO2006077428A1 Pharmaceutical compounds |
| 07/27/2006 | WO2006077426A2 4- (2, 6-DICHLOROBENZOYLAMINO) -lH-PYRAZOLE-3 -CARBOXYLIC ACID PIPERIDIN- 4 -YLAMID ACID ADDITION SALTS AS KINASE INHIBITORS |
| 07/27/2006 | WO2006077425A1 Combinations of pyrazole kinase inhibitors and further antitumor agents |
| 07/27/2006 | WO2006077424A1 Pharmaceutical compounds |